CINF vs LAB · P/E 16, rev $11.34B vs rev $174.4M
Cincinnati Financial Corporation (CINF) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CINF revenue for 2024-12-31 was $11.34B. Net income was $2.29B. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CINF currently screens at market cap $22.83B and trailing P/E 15.9. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CINF and LAB stock pages for the full models.
Not investment advice.